Insider Trading & Ownership - Klein Lawrence Otto

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Klein Lawrence Otto
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-03-23
Sale
2021-03-25
5:39 pm
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
100,000$128.05$12,805,240122,716
(Direct)
View
2021-01-15
Sale
2021-01-20
6:07 pm
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
25,000$215.2$5,379,94034,666
(Direct)
View
2020-06-24
Sale
2020-06-26
4:33 pm
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
70,000$75.88$5,311,56442,244
(Direct)
View
2020-05-11
Sale
2020-05-13
4:38 pm
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
25,000$60.4$1,509,97158,666
(Direct)
View
2019-07-10
Sale
2019-07-12
4:13 pm
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
Chief Business Officer
20,000$50.02$1,000,353155,753
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-06-07
Option Award
2023-06-08
6:44 pm
2024-06-07
2033-06-07
Jasper Therapeutics Inc.JSPRKlein Lawrence Otto
Director
47,000$047,000
(Direct)
View
2022-10-12
Option Award
2022-10-13
8:07 pm
N/A
N/A
Jasper Therapeutics Inc.JSPRKlein Lawrence Otto
Director
24,500$024,500
(Direct)
View
2022-08-16
Option Award
2022-08-18
5:36 pm
N/A
N/A
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
12,500$012,500
(Direct)
View
2022-07-05
Option Award
2022-07-06
6:20 pm
N/A
2030-07-30
Dyne Therapeutics Inc.DYNKlein Lawrence Otto
Director
7,222$07,222
(Direct)
View
2022-06-03
Option Award
2022-06-06
4:07 pm
N/A
2032-06-02
Dyne Therapeutics Inc.DYNKlein Lawrence Otto
Director
19,596$019,596
(Direct)
View
2022-03-21
Option Award
2022-03-23
6:05 pm
N/A
2032-03-21
Jasper Therapeutics Inc.JSPRKlein Lawrence Otto
Director
78,045$078,045
(Direct)
View
2022-03-10
Exercise
2022-03-14
6:03 pm
N/A
N/A
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
7,584$040,380
(Direct)
View
2022-03-14
Tax Withholding
2022-03-14
6:03 pm
N/A
N/A
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
1,229$61.0840,380
(Direct)
View
2022-03-11
Tax Withholding
2022-03-14
6:03 pm
N/A
N/A
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
1,883$62.5640,380
(Direct)
View
2022-02-18
Option Award
2022-02-22
5:41 pm
N/A
2032-02-18
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
66,600$066,600
(Direct)
View
2021-12-03
Exercise
2021-12-07
8:00 pm
N/A
N/A
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
26,667$035,658
(Direct)
View
2021-12-06
Tax Withholding
2021-12-07
8:00 pm
N/A
N/A
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
11,185$69.1735,658
(Direct)
View
2021-10-15
Option Award
2021-10-18
8:00 pm
N/A
2031-10-15
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
13,800$013,800
(Direct)
View
2021-09-10
Exercise
2021-09-14
9:44 pm
N/A
N/A
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
10,000$06,843
(Direct)
View
2021-09-10
Tax Withholding
2021-09-14
9:44 pm
N/A
N/A
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
10,000$06,843
(Direct)
View
2021-09-13
Tax Withholding
2021-09-14
9:44 pm
N/A
N/A
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
4,207$117.866,843
(Direct)
View
2021-05-26
Option Award
2021-05-27
8:38 pm
N/A
2031-05-25
Dyne Therapeutics Inc.DYNKlein Lawrence Otto
Director
19,596$019,596
(Direct)
View
2021-03-23
Exercise
2021-03-25
5:39 pm
N/A
2027-06-14
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
88,000$0122,716
(Direct)
View
2021-03-23
Exercise
2021-03-25
5:39 pm
N/A
N/A
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
12,000$44.67122,716
(Direct)
View
2021-03-23
Exercise
2021-03-25
5:39 pm
N/A
N/A
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
12,000$14.43122,716
(Direct)
View
2021-03-23
Exercise
2021-03-25
5:39 pm
N/A
N/A
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
10,000$29.87122,716
(Direct)
View
2021-03-23
Exercise
2021-03-25
5:39 pm
N/A
N/A
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
20,000$40.87122,716
(Direct)
View
2021-03-23
Exercise
2021-03-25
5:39 pm
N/A
N/A
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
12,000$17.66122,716
(Direct)
View
2021-03-23
Exercise
2021-03-25
5:39 pm
N/A
N/A
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
22,000$51.49122,716
(Direct)
View
2021-03-10
Exercise
2021-03-12
5:47 pm
N/A
N/A
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
4,583$058,384
(Direct)
View
2021-03-10
Tax Withholding
2021-03-12
5:47 pm
N/A
N/A
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
2,141$124.1558,384
(Direct)
View
2021-03-11
Option Award
2021-03-12
5:47 pm
N/A
2031-03-11
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
45,334$058,384
(Direct)
View
2021-01-15
Exercise(A)
2021-03-12
5:37 pm
N/A
N/A
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
16,334$14.4337,550
(Direct)
View
2021-01-15
Exercise
2021-01-20
6:07 pm
N/A
2026-07-14
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
25,000$034,666
(Direct)
View
2021-01-15
Exercise
2021-01-20
6:07 pm
N/A
N/A
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
16,344$14.4334,666
(Direct)
View
2021-01-15
Exercise
2021-01-20
6:07 pm
N/A
N/A
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
8,666$12.5734,666
(Direct)
View
2021-01-02
Tax Withholding
2021-01-04
4:12 pm
N/A
N/A
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
9,392$153.1110,608
(Direct)
View
2020-10-05
Option Award
2020-10-06
5:38 pm
N/A
2030-10-05
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
16,666$016,666
(Direct)
View
2020-09-21
Conversion
2020-09-23
7:04 pm
N/A
N/A
Dyne Therapeutics Inc.DYNKlein Lawrence Otto
Director
46,299$071,899
(Direct)
View
2020-07-31
Option Award
2020-09-23
7:04 pm
N/A
2030-07-30
Dyne Therapeutics Inc.DYNKlein Lawrence Otto
Director
25,600$071,899
(Direct)
View

Ownership
2020-09-16
8:43 pm
N/A
2029-09-05
Dyne Therapeutics Inc.DYNKlein Lawrence Otto
Director
0$069,133
(Direct)
View
2020-06-24
Exercise
2020-06-26
4:33 pm
N/A
2026-03-01
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
70,000$042,244
(Direct)
View
2020-06-24
Exercise
2020-06-26
4:33 pm
N/A
N/A
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
38,666$5.8642,244
(Direct)
View
2020-06-24
Exercise
2020-06-26
4:33 pm
N/A
N/A
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
31,334$12.5742,244
(Direct)
View
2020-05-11
Exercise
2020-05-13
4:38 pm
N/A
2026-03-01
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
25,000$058,666
(Direct)
View
2020-05-11
Exercise
2020-05-13
4:38 pm
N/A
N/A
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
25,000$5.8658,666
(Direct)
View
2020-03-10
Option Award
2020-03-12
4:10 pm
N/A
2030-03-10
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
CBO & COO
68,750$068,750
(Direct)
View
2019-12-03
Option Award
2019-12-05
4:05 pm
N/A
N/A
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
Chief Business Officer
40,000$040,000
(Direct)
View
2019-09-10
Option Award
2019-09-12
4:32 pm
N/A
N/A
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
Chief Business Officer
10,000$030,000
(Direct)
View
2019-07-10
Exercise
2019-07-12
4:13 pm
N/A
2026-03-01
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
Chief Business Officer
20,000$0155,753
(Direct)
View
2019-07-10
Exercise
2019-07-12
4:13 pm
N/A
N/A
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
Chief Business Officer
20,000$5.86155,753
(Direct)
View
2019-03-05
Option Award
2019-03-07
4:17 pm
N/A
2029-03-05
CRISPR Therapeutics AGCRSPKlein Lawrence Otto
Chief Business Officer
45,000$045,000
(Direct)
View
(A) Indicate amendment filing.